Dexcom generated approximately $100 million in revenue from its Stello consumer glucose monitoring product last year.

Growth in the medtech and healthcare IT sectors is expected to slow down before resuming in 2027.

Dexcom is developing AI-powered features for carb counting, allowing a patient to photograph a meal to predict its impact on their glucose levels.